PTC725

N/A

Report date: 2023/04/13 10:01:30
NME

Base Information

Drug NamePTC725
Drug Alias NamePTC-725PTC725
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNonstructural protein 4B inhibitors
TargetsNonstructural protein 4B
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPtc Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesPtc Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsHepatitis C
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A